Evidence map›Paper›PMID 33188184›Full record

ArticleNature communications2020

IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin.

Miao Tian, Xiumei Wang, Jihong Sun, Wenlong Lin, Lumin Chen, Shengduo Liu, Ximei Wu, Liyun Shi, Pinglong Xu, Xiujun Cai and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Gut microbes · 2025
    Article
  12. mSystems · 2025
    Article
  13. Article
  14. LncRNA BACE1-AS delays the propagation ofMicrobiology spectrum · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Miao Tian *Institute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, China.
Xiumei Wang *Institute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, China.
Jihong Sun *Department of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, China.
Wenlong LinInstitute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, China.
Lumin ChenDepartment of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 310016, Hangzhou, China.
Shengduo LiuThe MOE Key Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, 310058, Hangzhou, China.
Ximei WuDepartment of Pharmacology, School of Medicine, Zhejiang University, 310058, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0002-3316-893X
Liyun ShiDepartment of Immunology and Medical Microbiology, Nanjing University of Chinese Medicine, 210046, Nanjing, China.
Pinglong XuThe MOE Key Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, 310058, Hangzhou, China.ORCID http://orcid.org/0000-0001-7726-5443
Xiujun CaiDepartment of General Surgery, Innovation Center for Minimally Invasive Techniques and Devices, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 310016, Hangzhou, China. srrsh_cxj@zju.edu.cn.ORCID http://orcid.org/0000-0002-6457-0577
Xiaojian WangInstitute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, China. wangxiaojian@cad.zju.edu.cn.ORCID http://orcid.org/0000-0001-8232-0558
Zhejiang University · CNSir Run Run Shaw Hospital · CNFirst Affiliated Hospital Zhejiang University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Occurrence of Colorectal cancer (CRC) is relevant with gut microbiota. However, role of IRF3, a key signaling mediator in innate immune sensing, has been barely investigated in CRC. Here, we unexpectedly found that the IRF3 deficient mice are hyper-susceptible to the development of intestinal tumor in AOM/DSS and Apc

Indexed as

Animalsbeta CateninCarcinogenesisCell Line, TumorCell NucleusCell ProliferationColorectal NeoplasmsEnterocytesInterferon Regulatory Factor-3Intestinal MucosaKi-67 AntigenMice, Inbred C57BLProtein BindingProtein DomainsProtein TransportSurvival Analysisbeta CateninInterferon Regulatory Factor-3IRF3 protein, humanIrf3 protein, mouseKi-67 Antigen

Identifiers

PMID33188184
PMCPMC7666182
OpenAlexW3102755607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.